Trials / Completed
CompletedNCT00591331
Phototoxicity Potential of NatrOVA Creme Rinse - 1%
Phase 1 Evaluation of the Phototoxic Potential of NatrOVA Creme Rinse - 1% in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- ParaPRO LLC · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the primary irritation potential of NatrOVA Creme Rinse - 1% in humans, after exposure to UV radiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Spinosad (the active ingredient in NatrOVA) | This is a patch test in which the test material is applied to the patch and the patch applied to the skin. |
| DRUG | placebo |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2008-01-11
- Last updated
- 2008-05-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00591331. Inclusion in this directory is not an endorsement.